NanoCrystal® Technology

1,161

Published on

It is estimated that in excess of 40% of compounds in development suffer from poor solubility, making them difficult to develop and resulting in a significant number of potentially beneficial compounds being discarded in development each year. EDT’s NanoCrystal® technology addresses this key problem for the pharmaceutical industry.

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
1,161
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

×